Neumora Therapeutics (NMRA) Short Interest Ratio & Short Volume → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free NMRA Stock Alerts $9.95 +0.02 (+0.20%) (As of 06/7/2024 08:52 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Neumora Therapeutics Short Interest DataCurrent Short Interest6,310,000 sharesPrevious Short Interest6,580,000 sharesChange Vs. Previous Month-4.10%Dollar Volume Sold Short$61.02 millionShort Interest Ratio10.1 Days to CoverLast Record DateMay 15, 2024Outstanding Shares159,520,000 sharesFloat Size54,240,000 sharesShort Percent of Float11.63%Today's Trading Volume391,400 sharesAverage Trading Volume480,747 sharesToday's Volume Vs. Average81% Short Selling Neumora Therapeutics ? Sign up to receive the latest short interest report for Neumora Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNMRA Short Interest Over TimeNMRA Days to Cover Over TimeNMRA Percentage of Float Shorted Over Time Ad WealthPressNew trading system called MSFT, NVDA & MSFTLook 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.Just follow this link here! Neumora Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20246,310,000 shares $61.02 million -4.1%11.6%10.1 $9.67 4/30/20246,580,000 shares $59.81 million +12.1%12.3%11.2 $9.09 4/15/20245,870,000 shares $65.69 million +19.3%11.1%11.1 $11.19 3/31/20244,920,000 shares $67.65 million -2.2%10.1%10.8 $13.75 3/15/20245,030,000 shares $75.90 million +2.7%10.3%12.5 $15.09 2/29/20244,900,000 shares $86.39 million -2.0%10.1%17.1 $17.63 2/15/20245,000,000 shares $94.05 million +11.1%10.7%17.9 $18.81 1/31/20244,500,000 shares $67.05 million No Change9.3%16.7 $14.90 NMRA Short Interest - Frequently Asked Questions What is Neumora Therapeutics' current short interest? Short interest is the volume of Neumora Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 6,310,000 shares of NMRA short. 11.63% of Neumora Therapeutics' shares are currently sold short. Learn More on Neumora Therapeutics' current short interest. What is a good short interest ratio for Neumora Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NMRA shares currently have a short interest ratio of 10.0. Learn More on Neumora Therapeutics's short interest ratio. What is a good short interest percentage for Neumora Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.63% of Neumora Therapeutics' floating shares are currently sold short. Is Neumora Therapeutics' short interest increasing or decreasing? Neumora Therapeutics saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 6,310,000 shares, a decline of 4.1% from the previous total of 6,580,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Neumora Therapeutics' float size? Neumora Therapeutics currently has issued a total of 159,520,000 shares. Some of Neumora Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Neumora Therapeutics currently has a public float of 54,240,000 shares. How does Neumora Therapeutics' short interest compare to its competitors? 11.63% of Neumora Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Neumora Therapeutics: CRISPR Therapeutics AG (18.05%), Krystal Biotech, Inc. (9.84%), ImmunityBio, Inc. (38.03%), Immunovant, Inc. (15.25%), Twist Bioscience Co. (18.38%), Denali Therapeutics Inc. (8.09%), SpringWorks Therapeutics, Inc. (14.43%), Arcellx, Inc. (9.67%), Novavax, Inc. (32.26%), Apogee Therapeutics, Inc. (12.30%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Neumora Therapeutics stock? Short selling NMRA is an investing strategy that aims to generate trading profit from Neumora Therapeutics as its price is falling. NMRA shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Neumora Therapeutics? A short squeeze for Neumora Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NMRA, which in turn drives the price of the stock up even further. How often is Neumora Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NMRA, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: CRISPR Therapeutics Short Interest Data Krystal Biotech Short Interest Data ImmunityBio Short Interest Data Immunovant Short Interest Data Twist Bioscience Short Interest Data Denali Therapeutics Short Interest Data SpringWorks Therapeutics Short Interest Data Arcellx Short Interest Data Novavax Short Interest Data Apogee Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NMRA) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredAlert: Your Bank is Dying – Act Now or Lose Everything!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put...Priority Gold | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neumora Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neumora Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.